Steps Ahead, Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population

Completed · Phase 1/Phase 2

Conditions studied: Obesity

In brief

The Lower Mississippi Delta (LMD) population is characterized by high levels of overweight and obesity, which are the result of long-term disruptions in energy imbalance where dietary energy intake has exceeded energy expenditure associated with physical activity. To address this issue, the overall goal of this project is to determine ways in which the U.S. Department of Health and Human Services and U.S. Department of Agriculture Dietary Guidelines for Americans (2005) physical activity recommendations can be effectively adapted for the LMD population. Phase I of this study was completed in early 2011.

Key facts

Study ID

NCT01584596

Run by

Pennington Biomedical Research Center

People needed

129

Starts

2012-03-01

Expected to finish

2013-08-01

Last updated by the study team

2016-02-05

Who can join

Age: 35 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 35-64 years
• Body mass index (BMI) 25 to 34.9 kg/m2
• Physically capable of undertaking physical activity
• The capability and willingness to give written informed consent, to understand exclusion criteria, and to accept the randomized group assignment

You may not qualify if…

• Blood pressure greater than 159 mmHg systolic or 99 mmHg diastolic
• Total cholesterol greater than or equal to 240 mg/dl with LDL-C greater than or equal to 160 mg/dl or TG levels greater than or equal to 300 mg/dl
• Previously undiagnosed or uncontrolled Type 2 diabetes
• A past history and/or physical examination or laboratory findings of a medical condition including but not limited to chronic or recurrent cardiovascular, respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric conditions.
• Musculoskeletal problems interfering with exercise. Immunodeficiency diseases or a positive HIV test.
• Malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled.
• Any other medical condition or disease that is life-threatening or that can interfere with or be aggravated by exercise
• Pregnant or breastfeeding or plans to become pregnant within the next 4 months.
• Has taken any form of weight loss medication or medications known to affect weight in the past 30 days.
• Have begun taking any new regular prescription medications within the last 3 months (a 3 month stable dose is allowed)
• Planning on starting any new form of medication within the next 4 months
• Being an athlete or highly and regularly physically active (defined as 20 minutes of vigorous activity 3 times per week or 30 minutes of moderate activity 5 times per week)
• Participants not providing adequate accelerometry data i.e. who have not worn the device during waking hours for a full 7 days will be excluded at Visit 3.

Where it is running

• Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.